切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2023, Vol. 17 ›› Issue (03) : 240 -244. doi: 10.3877/cma.j.issn.1674-3946.2023.03.002

所属专题: 总编推荐 指南共识

专家论坛

中华医学会乳腺癌患者中心静脉血管通路临床实践指南解读
唐甜甜1, 马力1,()   
  1. 1. 050000 石家庄,河北医科大学第四医院乳腺中心
  • 收稿日期:2023-01-28 出版日期:2023-06-26
  • 通信作者: 马力

Interpretation of Chinese Medical Association central venous access clinical practice guidelines for breast cancer patients

Tiantian Tang1, Li Ma1,()   

  1. 1. Breast Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang Hebei Province 050000, China
  • Received:2023-01-28 Published:2023-06-26
  • Corresponding author: Li Ma
引用本文:

唐甜甜, 马力. 中华医学会乳腺癌患者中心静脉血管通路临床实践指南解读[J]. 中华普外科手术学杂志(电子版), 2023, 17(03): 240-244.

Tiantian Tang, Li Ma. Interpretation of Chinese Medical Association central venous access clinical practice guidelines for breast cancer patients[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(03): 240-244.

《中国乳腺癌中心静脉血管通路临床实践指南(2022版)》由中华医学会外科学分会乳腺学组组织制定,主要目的是规范乳腺癌患者中心静脉血管通路(CVA)的临床应用。不同的CVA在乳腺癌患者中的应用存在差异,本文就指南中关于不同CVA的适应证及禁忌证、通道选择、并发症的预防及处理及维护进行解读。

Clinical practice China guidelines on central venous vascular access for breast cancer(2022 edition)was made by the experts of the Chinese Society of Breast Surgery(CSBrS)of the Chinese Medical Association organized. The purpose of the guideline was to standardize application of CVA in the clinical practice of breast cancer patients. There has differences among different CVA when they used for breast cancer patients. We mainly interpret the indications and contraindications of different CVAs,channel selection,prevention and treatment of complications and maintenance of different CVAs in the guidelines.

图1 长期外周静脉化疗导致外周静脉炎
图3 不同CVA穿刺血管通路选择
图5 术中超声引导下静脉穿刺[26]
图6 静脉输液港感染
[1]
王啟瑶,莫霖,李霞,等. 颈内静脉与锁骨下静脉植入静脉输液港的有效性和安全性的Meta分析[J]. 解放军护理杂志201835(22):34-39,47.
[2]
Wu SHuang JJiang Z,et al. Internal jugular vein versus subclavian vein as the percutaneous insertion site for totally implantable venous access devices:a meta-analysis of comparative studies[J]. BMC Cancer201616(1):747.
[3]
Xu HChen RJiang C,et al. Implanting totally implantable venous access ports in the upper arm is feasible and safe for patients with early breast cancer[J]. J Vasc Access202021(5):609-614.
[4]
Kato KIwasaki YOnodera K,et al. Totally implantable venous access port via the femoral vein in a femoral port position with CT-venography[J]. J Surg Oncol2016114(8):1024-1028
[5]
李全磊,颜美琼,张晓菊,等. PICC经不同静脉和上肢置入对穿刺成功与并发症发生影响的系统评价[J]. 护理学杂志201227(21):56-62.
[6]
Merrer JDe Jonghe BGolliot F,et al. Complications of femoral and subclavian venous catheterization in critically ill patients:a randomized controlled trial[J]. JAMA2001286(6):700-707.
[7]
Parienti JJThirion MMégarbane B,et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy:a randomized controlled trial[J]. JAMA2008299(20):2413-2422.
[8]
Macdonald SWatt AJMcNally D,et al. Comparison of technical success and outcome of tunneled catheters inserted via the jugular and subclavian approaches[J]. J Vasc Interv Radiol200011(2 Pt 1):225-231.
[9]
Collier PERyan JJDiamond DL. Cardiac tamponade from central venous catheters. Report of a case and review of the English literature[J]. Angiology198435(9):595-600.
[10]
Chabanier ADany FBrutus P,et al. Iatrogenic cardiac tamponade after central venous catheter[J]. Clin Cardiol198811(2):91-99.
[11]
Sousa BFurlanetto JHutka M,et al. Central venous access in oncology:ESMO Clinical Practice Guidelines[J]. Ann Oncol2015,Suppl 5:v152-v168.
[12]
Pittiruti MHamilton HBiffi R,et al. ESPEN Guidelines on Parenteral Nutrition:central venous catheters(access,care,diagnosis and therapy of complications)[J]. Clin Nutr200928(4):365-377.
[13]
Glauser FBreault SRigamonti F,et al. Tip malposition of peripherally inserted central catheters:a prospective randomized controlled trial to compare bedside insertion to fluoroscopically guided placement[J]. Eur Radiol201727(7):2843-2849.
[14]
Gebhard RESzmuk PPivalizza EG,et al. The accuracy of electrocardiogram-controlled central line placement[J]. Anesth Analg2007104(1):65-70.
[15]
Practice Guidelines for Central Venous Access 2020:An Updated Report by the American Society of Anesthesiologists Task Force on Central Venous Access[J]. Anesthesiology2020132(1):8-43.
[16]
Lamperti MBodenham ARPittiruti M,et al. International evidence-based recommendations on ultrasound-guided vascular access[J]. Intensive Care Med201238(7):1105-1117.
[17]
Jo JETang EYPua BB. The role of antibiotics in preventing totally implantable venous access device(TIVAD)infections;is there a population that would benefit?[J]. Clin Imaging201851:213-216.
[18]
WST/T 433-2013. 静脉治疗护理技术操作规范(WS/T 433-2013[S/OL]. 中国:中华人民共和国国家卫生健康委员会,2013-11-14.
[19]
Gorski LAHadaway LHagle ME,et al. The 2016 infusion therapy standards of practice[J]. Journal of Infusion Nursing201639(1 Suppl):S1-S159.
[20]
Gorski LAHadaway LHagle ME,et al. Infusion therapy standards of practice,8th edition[J]. J Infus Nurs202144(1S Suppl 1):S1-S224.
[21]
中华医学会外科学分会乳腺外科学组. 乳腺癌植入式静脉输液港临床应用专家共识及技术操作指南(2017版)[J]. 中国实用外科杂志201737(12):1377-1382.
[22]
孙梅. 不同封管方法对植入式静脉输液港在乳腺癌中应用效果对比研究[J]. 检验医学与临床201310(22):3040-3042.
[23]
李倩芹. 肿瘤病人化疗期间PICC常见并发症的危险因素分析[J]. 全科护理202119(11):1558-1561.
[24]
Schreiber SZanchi CRonfani L,et al. Normal saline flushes performed once daily maintain peripheral intravenous catheter patency:a randomised controlled trial[J]. Arch Dis Child2015100(7):700-703.
[25]
中华人民共和国国家卫生健康委员会. 血管导管相关感染预防与控制指南(2021版)[J]. 中国感染控制杂志202120(04):387-388.
[26]
向泓雨,刘荫华. 制定高质量临床实践指南推动中国乳腺外科诊治规范化进程[J/CD]. 中华普外科手术学杂志(电子版),202216(02):119-122.
[1] 郏亚平, 曾书娥. 含鳞状细胞癌成分的乳腺化生性癌的超声与病理特征分析[J]. 中华医学超声杂志(电子版), 2023, 20(08): 844-848.
[2] 唐玮, 何融泉, 黄素宁. 深度学习在乳腺癌影像诊疗和预后预测中的应用[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 323-328.
[3] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[4] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[5] 施杰, 李云涛, 高海燕. 腋窝淋巴结阳性Luminal A型乳腺癌患者新辅助与辅助化疗的预后及影响因素分析[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 353-361.
[6] 伍秋苑, 陈佩贤, 邓裕华, 何添成, 周丹. 肠道微生物在乳腺癌中的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 362-365.
[7] 谭巧, 苏小涵, 侯令密, 黎君彦, 邓世山. 乳腺髓样癌的诊治进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 366-368.
[8] 周婉丽, 钱铮, 李喆. 槐耳在乳腺癌免疫治疗中的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 369-371.
[9] 熊倩, 罗凤. 乳腺癌患者术后康复现状与对策的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 372-374.
[10] 杨小菁, 姜瑞瑞, 石玉香, 王静静, 李长天. 乳腺孤立性纤维性肿瘤一例[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 375-377.
[11] 冯雪园, 韩萌萌, 马宁. 乳腺原发上皮样血管内皮瘤一例[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 378-380.
[12] 康一坤, 袁芃. 三阴性乳腺癌分子遗传学及临床特征研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 290-293.
[13] 王雪菲, 海琳悦, 李立方, 肖春花. Luminal A型乳腺癌的内分泌治疗与化疗[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 294-300.
[14] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[15] 李智铭, 郭晨明, 庄晓晨, 候雪琴, 高军喜. 早期乳腺癌超声造影定性及定量指标的对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 639-643.
阅读次数
全文


摘要